Literature DB >> 24040887

The level of control of mild asthma in general practice: an observational community-based study.

Marco Caminati1, Germano Bettoncelli, Maria Sandra Magnoni, Andrea Rizzi, Renato Testi, Gianni Passalacqua, Roberto De Marco, Gaetano Caramori, Gianenrico Senna.   

Abstract

OBJECTIVE: The aim of the present community-based study was to evaluate the level of asthma control in patients with mild asthma, regularly treated with inhaled steroids (ICS).
METHOD: This observational cross-sectional study included patients registered in the general practitioner (GP) database and with at least three prescriptions of ICS in the last 12 months. Patients were asked to refer to the doctor's office for a standardised interview. The level of asthma control was self-measured by the patients using the Asthma Control Test (ACT)™ (Quality Metric, Inc.).
RESULTS: The study included 950 asthmatic patients, referred by 540 GPs: 54.5% were females, mean age was 51 (±19.1) years; 59.5% were non-smokers, 22.5% were current smokers and 18.0% were former smokers; 81.1% of the patients were on ICS in the last 4 weeks. Only 38.6% of patients had a spirometry in the last 12 months. According to the ACT, 13.7% of the asthmatic patients were totally controlled, 51.0% well controlled, and 35.3% poorly controlled. Smoking habit, older age (>60) and living in Central or Southern Italy were associated with poorer control. In the last 12 months 4.5% of patients had an asthma-related hospitalisation, 5.3% an emergency visit and 18.9% a specialist visit.
CONCLUSIONS: More than one of three patients had poor asthma control, despite being considered by their GPs as mild asthmatics and treated with ICS. Asthmatic patients need to be regularly re-evaluated. Treatment is often inadequate and should be targeted to improve control and reduce asthma morbidity (SAM104964).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24040887     DOI: 10.3109/02770903.2013.843098

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  7 in total

1.  Disease control in patients with asthma and respiratory symptoms (wheezing, cough) during sleep.

Authors:  Jonathan Doenges; Elisabeth Kuckuck; Werner Cassel; Olaf Hildebrandt; Andreas Weissflog; Keywan Sohrabi; Niklas Koehler; Volker Gross; Timm Greulich; Ulrich Koehler
Journal:  Asthma Res Pract       Date:  2020-09-23

Review 2.  Small airway dysfunction and poor asthma control: a dangerous liaison.

Authors:  Marcello Cottini; Anita Licini; Carlo Lombardi; Diego Bagnasco; Pasquale Comberiati; Alvise Berti
Journal:  Clin Mol Allergy       Date:  2021-05-29

3.  Disease Burden of Mild Asthma: Findings from a Cross-Sectional Real-World Survey.

Authors:  Bo Ding; Mark Small
Journal:  Adv Ther       Date:  2017-04-08       Impact factor: 3.845

4.  Trends and determinants of Emergency Room admissions for asthma: A retrospective evaluation in Northeast Italy.

Authors:  Marco Caminati; Andrea Vianello; Giorgio Ricci; Giuliana Festi; Roberto Bellamoli; Sofia Longhi; Mariangiola Crivellaro; Guido Marcer; Marco Monai; Margherita Andretta; Chiara Bovo; Gianenrico Senna
Journal:  World Allergy Organ J       Date:  2019-07-03       Impact factor: 4.084

5.  The potential role of local pharmacies to assess asthma control: an Italian cross-sectional study.

Authors:  M Caminati; L Cegolon; M Bacchini; N Segala; A Dama; C Bovo; B Olivieri; F Furci; G Senna
Journal:  BMC Public Health       Date:  2021-01-05       Impact factor: 3.295

6.  Asthma under/misdiagnosis in primary care setting: an observational community-based study in Italy.

Authors:  Maria Sandra Magnoni; Marco Caminati; Gianenrico Senna; Fabio Arpinelli; Andrea Rizzi; Anna Rita Dama; Michele Schiappoli; Germano Bettoncelli; Gaetano Caramori
Journal:  Clin Mol Allergy       Date:  2015-11-16

Review 7.  Small airway dysfunction and bronchial asthma control : the state of the art.

Authors:  Marcello Cottini; Carlo Lombardi; Claudio Micheletto
Journal:  Asthma Res Pract       Date:  2015-12-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.